AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Find various ways to make money without any investment and kickstart your earning potential today.
26,836 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
MSCI pushes Indonesia’s market status review to November 2026, signaling patience amid ongoing reforms and watchful g...
Coca-Cola shares edge higher as a refreshed coca cola price prediction points to roughly 12% upside. Strong Q1 result...
As markets wobble in mid-2026, investors seek steady cash flow from blue-chip dividend names. This piece explains how...
Bitwise’s Matt Hougan argues that Strategy’s role as Bitcoin’s dominant corporate buyer is shifting as institutions s...
A ChatGPT-based forecast tied to Sam Altman envisions Bitcoin rising to $125K by end-2026, with a potential surge to ...
Oil prices surge as tensions around Iran intensify and the ceasefire appears cracking. Traders weigh supply disruptio...
IBM slumped 22% in early trading on a preliminary Q2 miss, igniting a wider tech sector selloff as analysts weigh AI ...
Bitcoin’s coins have gone quiet on-chain as older wallets pause after a two-year surge. Analysts warn the next move h...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
Democratic lawmakers are pushing the DOJ to reopen or strengthen antitrust scrutiny of the $1.6 billion Compass-Anywh...
Stocks faced a rough start to the week as tariff headlines rattled markets and Nvidia prepares its earnings reveal. L...